Earnings, Q3 FY2026YTD earnings strengthened; the JPY 190bn FY target remains, despite Q4 cost headwinds.SlidesCall transcriptInterim report
Earnings, Q2 FY2026R&D investments target high-margin growth in dermacosmetics and semiconductors, leveraging unique technologies.SlidesCall transcriptInterim report
Status updateAI-driven marketing tools and agile global teams are accelerating growth and efficiency worldwide.SlidesEvent transcript
Earnings, Q1 FY2026Q1 delivered strong profit growth and margin gains, with full-year outlook unchanged.SlidesCall transcriptInterim report
Earnings, Q4 FY2025Strong FY25 results and FY26 growth outlook, with focus on innovation and global expansion.SlidesCall transcriptInterim report
Earnings, Q3 FY2025Strong profit growth and margin expansion driven by recovery in cosmetics and cost controls.SlidesCall transcriptInterim report
Status updateTargets JPY 400B sales and 15% margin by 2027 via global brand focus and operational efficiency.SlidesEvent transcript
Earnings, Q2 FY2025Upward forecast revision reflects robust earnings, market share gains, and strategic reforms.SlidesCall transcriptInterim report
Earnings, Q1 FY2025Sales and profits rose sharply, led by cosmetics and UV Care, with guidance unchanged.SlidesCall transcriptInterim report
Earnings, Q4 FY2024Profit and margin growth exceeded targets, with 2025 set for further gains and global expansion.SlidesCall transcriptInterim report
Earnings, Q3 FY2024Profit and margin growth accelerated by reforms and premium products, despite China cosmetics drag.SlidesCall transcriptInterim report